scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in scPharmaceuticals Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −7 vs. Q2 2021
- Shares held
- 16.2M
- +201.2K (+1.3%) vs. Q2 2021
- Total value
- $107.9M
- +$10.0M (+10.2%) vs. Q2 2021
- New holders
- 2
- 12 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,797,148 | $31.9M | 0.35% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 3,831,474 | $25.5M | 5.17% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,731,170 | $18.2M | 0.25% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 1,234,121 | $8.21M | 2.43% | +591,967+92.2% | Added |
| Ikarian Capital, LLC | 901,362 | $5.99M | 1.37% | −193,662−17.7% | Reduced |
| J. Goldman & Co LP | 792,421 | $5.27M | 0.47% | +71,544+9.9% | Added |
| Vanguard Group Inc | 617,048 | $4.10M | 0.00% | +8,100+1.3% | Added |
| Worth Venture Partners, LLC | 300,760 | $2.00M | 0.90% | +136,766+83.4% | Added |
| Renaissance Technologies LLC | 193,586 | $1.29M | 0.00% | −22,900−10.6% | Reduced |
| Bridgeway Capital Management, LLC | 132,200 | $879.0K | 0.02% | +30,000+29.4% | Added |
| Jacobs Levy Equity Management, Inc | 102,207 | $680.0K | 0.00% | −36,397−26.3% | Reduced |
| Boothbay Fund Management, LLC | 86,635 | $576.0K | 0.02% | −38,192−30.6% | Reduced |
| Dimensional Fund Advisors LP | 79,265 | $527.0K | 0.00% | +34,438+76.8% | Added |
| Geode Capital Management, LLC | 71,223 | $473.0K | 0.00% | +4,748+7.1% | Added |
| Morgan Stanley | 70,093 | $465.0K | 0.00% | +8,929+14.6% | Added |
| BlackRock Inc. | 58,105 | $387.0K | 0.00% | −4,092−6.6% | Reduced |
| Northern Trust Corp | 50,110 | $333.0K | 0.00% | +225+0.5% | Added |
| Zacks Investment Management | 36,989 | $246.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 34,643 | $230.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 33,542 | $223.0K | 0.00% | −24,175−41.9% | Reduced |
| Ergoteles LLC | 27,116 | $180.0K | 0.01% | −756−2.7% | Reduced |
| HRT Financial LP | 16,189 | $107.0K | 0.00% | −4,072−20.1% | Reduced |
| State Street Corp | 14,000 | $93.0K | 0.00% | +14,000 | New |
| Envestnet Asset Management Inc | 10,696 | $71.0K | 0.00% | +10,696 | New |
| Advisor Group Holdings, Inc. | 3,857 | $25.0K | 0.00% | +3,500+980.4% | Added |
| Bank of America Corp | 1,154 | $8.00K | 0.00% | −339−22.7% | Reduced |
| UBS Group AG | 843 | $6.00K | 0.00% | +139+19.7% | Added |
| Barclays PLC | 814 | $5.00K | 0.00% | +44+5.7% | Added |
| Royal Bank of Canada | 79 | $1.00K | 0.00% | −795−91.0% | Reduced |
| BNP Paribas Arbitrage, SA | 106 | $705 | 0.00% | −153−59.1% | Reduced |
| Wells Fargo & Company | 60 | $0 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −194,238−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −115,264−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −38,891−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −23,614−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3,174−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,112−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −39−100.0% | Sold out |